Roopal B. Thakkar
Executive VP of Research & Development and Chief Scientific OfficerDr. Roopal B. Thakkar, M.D., has been Executive Vice President of Research & Development and Chief Scientific Officer of AbbVie Inc. since July 2024. He was Senior Vice President & Chief Medical Officer of Global Therapeutics at AbbVie Inc. since December 2023 until July 2024. He had been SVP of Development & Regulatory Affairs and Chief Medical Officer of AbbVie Inc. until December 2023. He joined Abbott/AbbVie in 2003 as part of the Physician Development Program. Since then, he has held several positions in clinical development, including Group Project Director, Immunology, as well as Vice President, Global Regulatory Affairs. In 2019, Dr. Thakkar assumed the role of Vice President, Global Regulatory Affairs and R&D Quality Assurance and was appointed to his current role in late 2022. Prior to joining AbbVie, he completed training in internal medicine and was a clinical fellow at the University of Alabama, Birmingham and at Wake Forest University School of Medicine. Dr. Thakkar received his B.S. in cellular and molecular biology from the University of Michigan and his M.D. from the Wayne State University School of Medicine.
Positions
- Company NameAbbVie Inc.Stock CodeABBVPositionExecutive VP of Research & Development and Chief Scientific OfficerColleagues
- RARobert A. MichaelCEO & Chairman of the Board
- STScott T. ReentsExecutive VP & CFO
- ASAzita SalekiExecutive VP & COO
- JRJeffrey Ryan StewartExecutive VP & Chief Commercial Officer
- TCThomas Craig FreymanIndependent Director
- FHFrederick H. WaddellIndependent Director
- BJBrett J. HartIndependent Director
- MBMelody Boone MeyerIndependent Director
